Successful deceased donor kidney transplantation to a recipient with a history of COVID-19 treatment.

Published on Mar 29, 2021in Journal of Infection and Chemotherapy2.211
路 DOI :10.1016/J.JIAC.2021.03.018
Kasumi Yoshinaga2
Estimated H-index: 2
(Okayama University),
Motoo Araki18
Estimated H-index: 18
+ 22 AuthorsYasutomo Nasu39
Estimated H-index: 39
(Okayama University)
Abstract Case presentation. A 49-year-old Asian male, who had undergone hemodialysis for >16 years, complained of a fever, dysgeusia and dysosmia, and was diagnosed with COVID-19 pneumonia based on severe acute respiratory syndrome coronavirus 2 polymerase chain reaction (SARS-CoV-2 PCR) and computed tomography (CT). Treatment was started with oral favipiravir and ciclesonide inhalation. On the 10th day of treatment, the patient had a persistent high fever and a chest CT showed exacerbation of pneumonia, so dexamethasone was intravenously started. He was discharged after confirming two consecutive negative SARS-CoV-2 PCR tests. Three months after COVID-19 treatment, a SARS-CoV-2 PCR test was negative and he underwent a deceased donor kidney transplantation. Basiliximab induction with triple drug immunosuppression consisting of extended-release tacrolimus, mycophenolate mofetil and prednisolone, which is our regular immunosuppression protocol, was used. He was discharged on postoperative day 18 without the need for postoperative hemodialysis or any complications. The serum creatinine level was 1.72 mg/dL 95 days postoperatively and he had a favorable clinical course that was similar to deceased donor kidney recipients without a history of SARS-CoV-2 infection. Conclusion. We report the first case of a kidney transplantation after COVID-19 treatment in Japan and the fourth case globally. We would like to provide information about our successful case due to the anticipated increase in similar candidates in the near future.
馃摉 Papers frequently viewed together
#1Prabhu KanchiH-Index: 1
Last. Ankur Gupta (Whakatane Hospital)H-Index: 28
view all 6 authors...
#1Giovanni VarottiH-Index: 16
#2Ferdinando DodiH-Index: 11
Last. Iris FontanaH-Index: 17
view all 4 authors...
COVID-19, the ongoing pandemic caused by SARS-CoV-2, has had a dramatic impact on transplant systems in the most affected countries, namely Italy. Preliminary data indicates that patients on hemodialysis therapy as well kidney transplant (KTx) recipients appear to be particularly susceptible to COVID-19 illness due to immunosuppression and coexisting conditions. Currently, there is a lack of data concerning the biologic behavior, recurrence and long-term morbidity of COVID-19 and there are no ex...
#1Kan KikuchiH-Index: 11
#2Masaomi Nangaku (UTokyo: University of Tokyo)H-Index: 84
Last. Tadao Akizawa (Memorial Hospital of South Bend)H-Index: 1
view all 11 authors...
In Japan, the first case of COVID-19 in dialysis patients was reported on March 1, 2020. A total of 31 cases were reported by April 10, and it increased to 95 by May 15. Thereafter, with the rapid increase in the number of COVID-19 cases in the general population since late March, there was a not surprising increase in the number of COVID-19 cases in dialysis patients. The mortality rate is 16.2% (16/99 cases) in dialysis patients, which is higher than 5.3% (874/16532 cases) in the general popul...
#1Claudia Benedetti (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 4
#2Meryl Waldman (NIH: National Institutes of Health)H-Index: 18
Last. Paolo Cravedi (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 39
view all 5 authors...
Novel coronavirus disease 2019 (COVID-19) has become a worldwide emergency health problem. The disease occurs mostly in individuals between 30-79 years of age and 81% of cases are mild. However, it may result in progressive respiratory failure owing to alveolar damage and can be fatal in 3.6% of the cases. Direct viral injury, uncontrolled inflammation, and activation of coagulation and complement cascades are thought to participate in disease pathogenesis. Patients with COVID-19 often display k...
#1Paolo Cravedi (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 39
#2Suraj Sarvode Mothi (Brigham and Women's Hospital)H-Index: 9
Last. Leonardo V. Riella (Harvard University)H-Index: 29
view all 24 authors...
Kidney transplant recipients may be at high risk of developing critical COVID-19 illness due to chronic immunosuppression and comorbidities. We identified hospitalized adult kidney transplant recipients at 12 transplant centers in the US, Italy and Spain who tested positive for COVID-19. Clinical presentation, laboratory values, immunosuppression and treatment strategies were reviewed and predictors of poor clinical outcomes were determined through multivariable analyses. Among 9,845 kidney tran...
#1Federico Alberici (University of Brescia)H-Index: 22
#2Elisa DelbarbaH-Index: 7
Last. Francesco Scolari (University of Brescia)H-Index: 57
view all 15 authors...
Abstract The outcome of SARS-CoV2 infection in patients who have received a kidney allograft and are being treated with immunosuppression is unclear. We describe 20 kidney transplant recipients (median age 59 years [inter quartile range 51-64 years], median age of transplant 13 years [9-20 years], baseline eGFR 36.5 [23-47.5]) with SARS-CoV2 induced pneumonia. At admission, all had immunosuppression withdrawn and were started on methylprednisolone 16 mg/day, all but one was commenced on antivira...
#1Saraladevi Naicker (University of the Witwatersrand)H-Index: 30
#2Chih-Wei Yang (CGU: Chang Gung University)H-Index: 45
Last. Vivekanand Jha (UNSW: University of New South Wales)H-Index: 112
view all 6 authors...
#1Xi He (Guangzhou Medical University)H-Index: 8
#2Eric H. Y. Lau (HKU: University of Hong Kong)H-Index: 39
Last. Gabriel M. Leung (HKU: University of Hong Kong)H-Index: 98
view all 23 authors...
We report temporal patterns of viral shedding in 94 patients with laboratory-confirmed COVID-19 and modeled COVID-19 infectiousness profiles from a separate sample of 77 infector鈥搃nfectee transmission pairs. We observed the highest viral load in throat swabs at the time of symptom onset, and inferred that infectiousness peaked on or before symptom onset. We estimated that 44% (95% confidence interval, 25鈥69%) of secondary cases were infected during the index cases鈥 presymptomatic stage, in setti...
#1Brandon Michael Henry (Cincinnati Children's Hospital Medical Center)H-Index: 36
#2Giuseppe Lippi (University of Verona)H-Index: 116
Cited By2
#1Erica C. Bjornstad (UAB: University of Alabama at Birmingham)H-Index: 3
#2Michael E. Seifert (UAB: University of Alabama at Birmingham)H-Index: 12
Last. Daniel I. Feig (UAB: University of Alabama at Birmingham)H-Index: 47
view all 4 authors...
Research indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection can impact every organ, and the effects can range from asymptomatic to severe disease. Since it was first discovered in December 2019, our understanding has grown about its impact on kidney disease. In general, children have less severe disease than adults, and this tendency appears to extend to special pediatric kidney populations (e.g., chronic kidney disease and immunosuppressed patients with solid o...
#1Sof铆a de la Villa (Hospital General Universitario Gregorio Mara帽贸n)H-Index: 3
#2Maricela Valerio (Hospital General Universitario Gregorio Mara帽贸n)H-Index: 22
Last. Jos茅 A. L贸pez-Baena (Hospital General Universitario Gregorio Mara帽贸n)H-Index: 3
view all 14 authors...
At present, there is unclear evidence on the need for a negative SARS-CoV-2 RT-PCR for donors with a history of COVID-19 prior to transplantation 1,2 . We report two cases of heart and liver recipients from a donor with previous documented COVID-19 and positive RT-PCR at time of transplantation.
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.